Pine bark may relieve the bite of psoriasis, according to a new study published in Panminerva Medica, a journal of internal medicine. Psoriasis is the most prevalent autoimmune disease in the U.S., impacting nearly 8 million Americans, noted Naturalproductsinsider, where the study was noted.
Researchers studied subjects ranging in age between 30-45 with moderate to severe plaque psoriasis for 12 weeks. They were given 50 mg of Pycnogenol French maritime pine bark extract three times daily. Researchers measured the levels of oxidative stress (plasma free radicals) and patients reported conditions in the Dermatology Life Quality Index (DLQI).
The researchers found that the patients who took the pine bark had a decrease in the areas of skin affected by psoriasis as well as a decrease in the severity of the condition. Improvements in the treatment time and the costs were observed in the supplemented group. Oxidative stress was significantly lower in the supplement group at the end of the study.
The study’s authors wrote that their findings indicated the “efficacy of Pycnogenol supplementation in improving control of the most common clinical aspects of psoriasis and in reducing oxidative stress. Further studies may indicate the possible systemic or local use of Pycnogenol and its role in controlling side effects and costs of standard management.”
Another recent study suggested that Pycnogenol may improve performance and endurance while reducing cramping and soreness after exercise. That research appeared in the Journal of Sports Medicine and Physical Fitness.